Literature DB >> 7201803

Behavioral effects of nimodipine in animals.

F Hoffmeister, U Benz, A Heise, H P Krause, V Neuser.   

Abstract

Neuro- and psychopharmacological effects of isopropyl-(2-methoxy-ethyl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate (Bay e 9736, nimodipine) are described using a variety of methods measuring behavior under normal conditions, under the influence of psychotropic drugs, as well as under the influence of ischemia or hypoxia. It has been demonstrated that nimodipine -- although not being very potent when measured in mg/kg -- exerts neuro- and psychopharmacological effects characterized by influences on the extrapyramidal system, aggressive defensive behavior, and chemically induced seizures. Electroencephalographical changes become evident whenever the normal equilibrium between cerebral catecholamine and cerebral serotonin levels is disturbed. When measured under the contingencies of a one trial passive avoidance paradigm, nimodipine is able to prevent the occurrence of retrograde amnesia in rodents after amnesiogenic events such as maximal electroconvulsive seizure or hypoxia. The substance prevents behavioral and electroencephalographic disturbances, elicited by a total cerebral ischemia, which is lethal in non-treated cats. It is concluded that nimodipine besides being a cerebrally vasoactive agent has psychopharmacological properties with a profile of actions hitherto unknown.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7201803

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  32 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Enhancing effects of Hoe 175 on memory in mice.

Authors:  F J Hock; J L McGaugh
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  A bout analysis reveals age-related methylmercury neurotoxicity and nimodipine neuroprotection.

Authors:  Andrew Nathanael Shen; Craig Cummings; Derek Pope; Daniel Hoffman; M Christopher Newland
Journal:  Behav Brain Res       Date:  2016-05-16       Impact factor: 3.332

5.  [Effect of the Ca antagonist nimodipine on global and regional cerebrovascular circulation].

Authors:  M R Gaab; C P Rode; E H Schakel; I Haubitz; J Bockhorn; A Brawanski
Journal:  Klin Wochenschr       Date:  1985-01-02

Review 6.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

7.  Evidence of multiple receptor sites within the putative calcium channel.

Authors:  D R Ferry; H Glossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

8.  Behavioral performance effects of nifedipine in normotensive and renovascular hypertensive baboons.

Authors:  J S Turkkan; R D Hienz
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  Comparison of the effects of bifemelane hydrochloride, idebenone and indeloxazine hydrochloride on ischemia-induced changes in brain monoamines and their metabolites in gerbils.

Authors:  K Haba; N Ogawa; M Asanuma; H Hirata; A Mori
Journal:  J Neural Transm Gen Sect       Date:  1992

10.  Inhibition of lipid peroxidation by some dihydropyridine derivatives.

Authors:  A Sakamoto; S T Ohnishi; R Ogawa
Journal:  J Anesth       Date:  1993-04       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.